首页> 美国卫生研究院文献>Cell Transplantation >Extracellular Vesicles Derived from Human Umbilical Cord MesenchymalStromal Cells Protect Cardiac Cells Against Hypoxia/Reoxygenation Injury byInhibiting Endoplasmic Reticulum Stress via Activation of the PI3K/AktPathway
【2h】

Extracellular Vesicles Derived from Human Umbilical Cord MesenchymalStromal Cells Protect Cardiac Cells Against Hypoxia/Reoxygenation Injury byInhibiting Endoplasmic Reticulum Stress via Activation of the PI3K/AktPathway

机译:来自人脐带间充质的细胞外囊泡基质细胞保护心脏细胞免受缺氧/雷诺损伤的影响通过激活PI3K / AKT抑制内质网胁迫途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Endoplasmic reticulum (ER) stress is implicated in the pathogenesis of manydiseases, including myocardial ischemia/reperfusion injury. We hypothesized thathuman umbilical cord mesenchymal stromal cells derived extracellular vesicles(HuMSC-EVs) could protect cardiac cells against hyperactive ER stress induced byhypoxia/reoxygenation (H/R) injury. The H/R model was generated using the H9c2cultured cardiac cell line. HuMSC-EVs were extracted using a commerciallyavailable exosome isolation reagent. Levels of apoptosis-related signalingmolecules and the degree of ER stress were assessed by western blot. The role ofthe PI3K/Akt pathway was investigated using signaling inhibitors. Lactatedehydrogenase leakage and 3-(4,5-Dimethylthiazol-2-yl)-2,5-DiphenyltetrazoliumBromide (MTT) analysis were used for evaluating the therapeutic effects ofHuMSC-EVs in vitro. The results showed that ER stress and therate of apoptosis were increased in the context of H/R injury. Treatment withHuMSC-EVs inhibited ER stress and increased survival in H9c2 cells exposed toH/R. Mechanistically, the PI3K/Akt pathway was activated by treatment withHuMSC-EVs after H/R. Inhibition of the PI3K/Akt pathway by a specific inhibitor,LY294002, partially reduced the protective effect of HuMSC-EVs. Our findingssuggest that HuMSC-EVs could alleviate ER stress–induced apoptosis during H/Rvia activation of the PI3K/Akt pathway.
机译:内质网(ER)应激涉及许多人的发病机制疾病,包括心肌缺血/再灌注损伤。我们假设这一点人脐带间充质基质细胞衍生的细胞外囊泡(HUMSC-EVS)可以保护心脏细胞免受诱导的多动态应激缺氧/雷诺(H / R)损伤。使用H9C2产生H / R模型培养的心脏细胞系。使用商业上提取HUMSC-EVS可用外出隔离试剂。凋亡相关信号传导的水平通过Western印迹评估分子和ER压力的程度。角色使用信号抑制剂研究PI3K / AKT途径。乳酸脱氢酶渗漏和3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑鎓溴(MTT)分析用于评估治疗效果Humsc-evs体外。结果表明,呃压力和在H / R损伤的背景下增加凋亡率。治疗HUMSC-EVS抑制ER应激并增加暴露于H9C2细胞的存活率h / r。机械地,通过用处理激活PI3K / AKT途径H / R后的HUMSC-EVS。特异性抑制剂抑制PI3K / AKT途径,LY294002,部分减少了HUMSC-EVS的保护作用。我们的研究结果表明HUMSC-EV可以缓解H / R期间的ER应激诱导的细胞凋亡通过激活PI3K / AKT路径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号